Michala C. Prause

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Protection of beta cells against cytokine-induced apoptosis by the gut microbial metabolite butyrate.

Protection of beta cells against cytokine-induced apoptosis by the gut microbial metabolite butyrate.

Journal: The FEBS journal

Published: July 04, 2024

Butyrate functions as a histone deacetylase inhibitor to protect pancreatic beta cells from IL-1β-induced dysfunction.

Butyrate functions as a histone deacetylase inhibitor to protect pancreatic beta cells from IL-1β-induced dysfunction.

Journal: The FEBS journal

Published: July 31, 2023

Targeted Delivery of Butyrate Improves Glucose Homeostasis, Reduces Hepatic Lipid Accumulation and Inflammation in db/db Mice.

Targeted Delivery of Butyrate Improves Glucose Homeostasis, Reduces Hepatic Lipid Accumulation and Inflammation in db/db Mice.

Journal: International journal of molecular sciences

Published: January 30, 2023

Beta cell dysfunction induced by bone morphogenetic protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding.

Beta cell dysfunction induced by bone morphogenetic protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding.

Journal: Cell death & disease

Published: November 11, 2022

Butyrate inhibits IL-1β-induced inflammatory gene expression by suppression of NF-κB activity in pancreatic beta cells.

Butyrate inhibits IL-1β-induced inflammatory gene expression by suppression of NF-κB activity in pancreatic beta cells.

Journal: The Journal of biological chemistry

Published: February 21, 2022

Butyrate Protects Pancreatic Beta Cells from Cytokine-Induced Dysfunction.

Butyrate Protects Pancreatic Beta Cells from Cytokine-Induced Dysfunction.

Journal: International journal of molecular sciences

Published: September 08, 2021

SKAP2, a Candidate Gene for Type 1 Diabetes, Regulates β-Cell Apoptosis and Glycemic Control in Newly Diagnosed Patients.

SKAP2, a Candidate Gene for Type 1 Diabetes, Regulates β-Cell Apoptosis and Glycemic Control in Newly Diagnosed Patients.

Journal: Diabetes

Published: January 29, 2020

Beta-cell dysfunction induced by non-cytotoxic concentrations of Interleukin-1β is associated with changes in expression of beta-cell maturity genes and associated histone modifications.

Beta-cell dysfunction induced by non-cytotoxic concentrations of Interleukin-1β is associated with changes in expression of beta-cell maturity genes and associated histone modifications.

Journal: Molecular and cellular endocrinology

Published: February 19, 2019

Cytokines and Pancreatic β-Cell Apoptosis.

Cytokines and Pancreatic β-Cell Apoptosis.

Journal: Advances in clinical chemistry

Published: June 28, 2016

TRAF2 mediates JNK and STAT3 activation in response to IL-1β and IFNγ and facilitates apoptotic death of insulin-producing β-cells.

TRAF2 mediates JNK and STAT3 activation in response to IL-1β and IFNγ and facilitates apoptotic death of insulin-producing β-cells.

Journal: Molecular and cellular endocrinology

Published: August 05, 2015

JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression.

JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression.

Journal: Journal of diabetes research

Published: June 04, 2015

JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis.

JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis.

Journal: PloS one

Published: September 23, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026